BackNurix Therapeutics Overview

Nurix Therapeutics Cost of Revenue

Cost of Revenue analysis for NRIX.

Quarterly Cost of Revenue

$84.14M
↑ 1938.2% YoY

As of Feb 28, 2026

Annual Cost of Revenue (TTM)

$93.77M
↑ 1040.87% YoY

Trailing 12 months ending Feb 28, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin